Compare IEP & NVST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IEP | NVST |
|---|---|---|
| Founded | 1987 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 4.0B |
| IPO Year | 1987 | 2019 |
| Metric | IEP | NVST |
|---|---|---|
| Price | $7.93 | $23.85 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 14 |
| Target Price | N/A | ★ $21.85 |
| AVG Volume (30 Days) | 1.1M | ★ 2.2M |
| Earning Date | 02-25-2026 | 02-05-2026 |
| Dividend Yield | ★ 25.16% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.09 |
| Revenue | ★ $9,257,000,000.00 | $2,621,800,000.00 |
| Revenue This Year | N/A | $7.42 |
| Revenue Next Year | N/A | $3.63 |
| P/E Ratio | ★ N/A | $279.62 |
| Revenue Growth | N/A | ★ 4.73 |
| 52 Week Low | $7.08 | $14.22 |
| 52 Week High | $10.74 | $25.41 |
| Indicator | IEP | NVST |
|---|---|---|
| Relative Strength Index (RSI) | 54.39 | 57.09 |
| Support Level | $7.82 | $23.70 |
| Resistance Level | $8.15 | $25.08 |
| Average True Range (ATR) | 0.17 | 0.79 |
| MACD | 0.03 | -0.07 |
| Stochastic Oscillator | 51.38 | 46.03 |
Icahn Enterprises LP provides diversified business services in the United States. The company operates its business through varied segments which include Investment, Automotive, Energy, Food Packaging, Real Estate, Pharma, and Home Fashion. Among these, the Energy segment derives the maximum revenue from the company. Geographically, it generates maximum revenue from the United States.
Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments; Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment, which derives key revenue, develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. Geographically, the company generates a majority of its revenue from North America, followed by Western Europe and other developed and emerging markets.